Article
Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.
Oncogene - 5 Jun 2014
Ogino S, Lochhead P, Giovannucci E, Meyerhardt J A, Fuchs C S, Chan A T
Abstract excerpt
Regular use of aspirin reduces incidence and mortality of various cancers, including colorectal cancer. Anticancer effect of aspirin represents one of the 'Provocative Questions' in cancer research. Experimental and clinical studies support a carcinogenic role for PTGS2 (cyclooxygenase-2), which is an important enzymatic mediator of inflammation, and a target of aspirin. Recent 'molecular pathological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
